2 July 2020
Duke Royalty Limited
("Duke Royalty", "Duke" or the "Company")
Scrip Dividend Reference Price
Further to its announcement on 17 June 2020 regarding the payment of 0.5p per share to shareholders by way of a scrip dividend for the upcoming June quarter dividend, Duke Royalty announces that the scrip dividend reference price for the ordinary shares to be issued to shareholders will be 26.45p. This has been calculated using the trailing five-day average mid-market closing price to 1 July 2020.
Accordingly, on 10 July 2020 shareholders will receive payment in new ordinary shares based on the following formula:
(Number of ordinary shares held at the record date of 26 June X 0.5p) ÷ 26.45p
A further announcement will be made shortly to confirm the exact number of new ordinary shares to be issued once rounding of individual shareholder allocations has been confirmed by the Company's registrar. An application will be made for these shares to be admitted to trading on AIM on 10 July 2020.
For further information, please contact www.dukeroyalty.com, or contact:
Duke Royalty Limited
Neil Johnson / Charlie Cannon Brookes / Hugo Evans
+44 (0) 1481 741 240
Cenkos Securities plc
(Nominated Adviser and Broker)
Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson
+44 (0) 207 397 8900
Newgate Communications (PR)
Elisabeth Cowell/ Ian Silvera/ Megan Kovach
+ +44 (0) 20 3757 6880 email@example.com
About Duke Royalty
Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.